Qubit Pharmaceuticals
Paris, FR · Founded 2020 · 57 employees on LinkedIn · 3 known investors
Find your way into Qubit Pharmaceuticals
Qubit Pharmaceuticals develops novel drug candidates using quantum physics, AI, and computational chemistry through its ATLAS platform for high-precision molecular simulation, modeling, and molecule generation. Its pipeline focuses on oncology, inflammation, and antiviral/pandemic-response programs, with fully owned and partnered drug discovery projects.
Founders & leadership
Investors · 3
How we know: Quantonation's portfolio page · funding news · quantonation.com · the VCSheet dataset · Not right? Tell us
How we know: XAnge's portfolio page · funding news · Not right? Tell us
How we know: press coverage · Not right? Tell us
Funding
SEC filings, press & company announcements- Undisclosed amountSeed RoundJun 2022 · 2 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Qubit Pharmaceuticals do?
- Qubit Pharmaceuticals develops novel drug candidates using quantum physics, AI, and computational chemistry through its ATLAS platform for high-precision molecular simulation, modeling, and molecule generation. Its pipeline focuses on oncology, inflammation, and antiviral/pandemic-response programs, with fully owned and partnered drug discovery projects.
- Who are Qubit Pharmaceuticals's investors?
- Qubit Pharmaceuticals's investors include Quantonation, XAnge, Omnes Capital.
- Where is Qubit Pharmaceuticals headquartered?
- Qubit Pharmaceuticals is headquartered in Paris, FR.




